Huvepharma Inc is categorized under Wholesale Pharmaceutical Products in Saint Louis, MO and active since 2007.
Huvepharma Inc was established in 2007, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Kiril Domuschiev at the company’s single location by writing to 3360 Maury Avenue, Saint Louis, Missouri MO 63116 or by phoning (314) 752-3521. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Huvepharma Inc |
Contact Person: | Kiril Domuschiev |
Address: | 3360 Maury Avenue, Saint Louis, Missouri 63116 |
Phone Number: | (314) 752-3521 |
Website Address: | huvepharma.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 4461100 |
Share This Business: |
Huvepharma Inc was started in 2007 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Kiril Domuschiev for inquiries that concern Huvepharma Inc by calling the company number (314) 752-3521, as your correspondence is most welcome. Additionally, the physical location of the single location of Huvepharma Inc can be found at the coordinates 38.59569,-90.26869 as well as the street address 3360 Maury Avenue in Saint Louis, Missouri 63116.
For its online presence, you may visit Huvepharma Inc’s website at huvepharma.com and engage with its social media outlets through on Twitter and on Facebook.